Jodie Hay Institute of Cancer Sciences University of Glasgow Biography Publications Institution JoVE Articles Jodie HayResearch Associate Jodie Hay is a Research Associate at the Paul O'Gorman Leukaemia Research Centre part of the University of Glasgow. She received her undergraduate with honours degree in Forensic Science with Chemistry from The Robert Gordon University, Aberdeen, and a Ph.D. in Medicine from the Queen's University Belfast.During Dr Hay's training she has worked on a number of haematological malignancies including AML, T-ALL and B cell lymphoma. She joined the Michie group in 2018 as a senior postdoctoral research scientist to explore the cellular and molecular mechanisms that underlie the initiation and progression of chronic lymphocytic leukaemia (CLL), with a view to identifying novel targets for therapeutic intervention. Publications Collaboration of MYC and RUNX2 in Lymphoma Simulates T-cell Receptor Signaling and Attenuates P53 Pathway Activity Journal of Cellular Biochemistry. Oct, 2019 | Pubmed ID: 31257681 AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2019 | Pubmed ID: 30559170 RUNX-mediated Growth Arrest and Senescence Are Attenuated by Diverse Mechanisms in Cells Expressing RUNX1 Fusion Oncoproteins Journal of Cellular Biochemistry. 03, 2018 | Pubmed ID: 29052866 Integrated Analysis of the Molecular Action of Vorinostat Identifies Epi-sensitised Targets for Combination Therapy Oncotarget. Sep, 2017 | Pubmed ID: 28978082 RUNX Oncoproteins and MiRNA Networks Oncotarget. Sep, 2017 | Pubmed ID: 28968950 The RUNX Genes As Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models Advances in Experimental Medicine and Biology. Month, 2017 | Pubmed ID: 28299662 Addiction to Runx1 is Partially Attenuated by Loss of P53 in the Eµ-Myc Lymphoma Model Oncotarget. Apr, 2016 | Pubmed ID: 27056890 Subcellulære fraktionering af primære kroniske Lymfocytiske leukæmiceller til at overvåge nuklear/cytoplasmisk protein handel Jodie Hay*1, Michael W. Moles*1, Jennifer Cassels1, Alison M. Michie1 1Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow JoVE 60426 Cancer Research
Subcellulære fraktionering af primære kroniske Lymfocytiske leukæmiceller til at overvåge nuklear/cytoplasmisk protein handel Jodie Hay*1, Michael W. Moles*1, Jennifer Cassels1, Alison M. Michie1 1Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow JoVE 60426 Cancer Research
